Literature DB >> 15098980

Treatment of Hailey-Hailey disease with tacrolimus ointment and clobetasol propionate foam.

Saleem A Umar1, Pradip Bhattacharjee, Robert T Brodell.   

Abstract

Hailey-Hailey disease, or familial benign chronic pemphigus, is a chronic disease without a known cure. Current therapeutic strategies attempt to suppress Hailey-Hailey outbreaks and allow the patient to live comfortably with this condition. We have found that applying topical tacrolimus 0.1% ointment (Protopic) twice a day to affected areas is an excellent way to control Hailey-Hailey disease. In addition to effectively controlling Hailey-Hailey outbreaks, tacrolimus is a relatively safe and noninvasive mode of treatment, without significant side effects. We recommend intermittent therapy with clobetasol propionate 0.05% foam (Olux Foam) for patients who break through suppressive therapy with tacrolimus a few times per year. In patients with frequent outbreaks of Hailey-Hailey disease despite suppressive therapy with tacrolimus, we recommend alternating the tacrolimus with clobetasol propionate 0.05% foam every 6 weeks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098980

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  2 in total

1.  Chronic vulvocrural dermatitis with burning and itching.

Authors:  Maria Le Donne; Maria Lentini; Giovanna Moretti; Serafinella Patrizia Cannavò
Journal:  CMAJ       Date:  2008-09-09       Impact factor: 8.262

Review 2.  Management of familial benign chronic pemphigus.

Authors:  Harleen Arora; Fleta N Bray; Jessica Cervantes; Leyre A Falto Aizpurua
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.